CTNM Contineum Therapeutics Inc. - Ordinary Shares - Class A

$CTNM $236.55 million total cash and marketable securities position against $6.57 million in total debt

$CTNM - $6.79 per share in cash. Pretty much a risk free bet. I would think a competitor of $BMY would be very interested at this level. Buy out at $15?

$CTNM PIPE-791 is better than admilparant - should permit efficacy at lower doses with fewer side effects. So I view today's admilparant data as quite positive for PIPE-791 as it show the target works. Buying some CTNM today as a swing trade - should bounce back.

$CTNM you'd think after losing 35 percent of their market cap they'd release some kind of statement

washed out names don't stay washed out forever imo $CTNM closed $8.46 Tuesday, up 13.7 percent off a $7.44 close it slid 37.6 percent in a month toward that $6.95 low, then bounced on 2.2 million shares with no single headline driving it PIPE 791 Phase 2 in IPF and chronic pain is the work I am watching here. covering can start a turn ngl

$CTNM bearish; a company holding $236.6M of cash that just printed its second straight Phase 2 failure is a liquidation still looking for an exit. It now trades barely above its own bank balance, which tells you the market stopped paying for science and started paying for a wind-down.

$CTNM Robinhood shows no shares available to short. Vultures surrounding it on not bad news. If we can get a little volume maybe we can climb back to the double digits. Maybe.

$CTNM Whew, threw a 200 share dart at $8.50 on a lark and it shot right back... took $10.11, almost instantly, dropped again, now back up. Can't be just a rogue drop, right... what's going on???? Not seeing anything as of yet.